Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years

This study is currently recruiting participants.
Information provided by Ception Therapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Eosinophilic Esophagitis
2		Additional conditions recognized in this trial
			Esophagitis
3		More general conditions related to this trial
			Digestive System Diseases
			Esophageal Diseases
			Gastroenteritis
			Gastrointestinal Diseases
4		Interventions listed in this trial
			Reslizumab
			Saline
5		Sponsors listed in this trial
			Ception Therapeutics